UB Paderborn / Katalog / Suche / in CDI

1 – 18 von 18

Sortiert nach

Ibrutinib-associated ventricular arrhythmia in the FDA Adverse Event Reporting System

Leukemia & lymphoma, 2018-12, Vol.59 (12), p.3016-3017

2018

Volltextzugriff (PDF)

Hemolytic anemia following alectinib reported to the U.S. Food and Drug Administration Adverse Event Reporting System

American journal of hematology, 2022-04, Vol.97 (4), p.E129-E132

2022

Volltextzugriff (PDF)

Arterial aneurysm and dissection with systemic vascular endothelial growth factor inhibitors: A review of cases reported to the FDA Adverse Event Reporting System and published in the literature

Vascular medicine (London, England), 2021-10, Vol.26 (5), p.526-534

2021

Volltextzugriff (PDF)

Ibrutinib‐associated Pneumocystis jirovecii pneumonia

American journal of hematology, 2017-11, Vol.92 (11), p.E646-E648

2017

Volltextzugriff (PDF)

Wound healing complications with lenvatinib identified in a pharmacovigilance database

Journal of oncology pharmacy practice, 2019-12, Vol.25 (8), p.1817-1822

2019

Volltextzugriff (PDF)

Photosensitivity associated with anaplastic lymphoma kinase inhibitors: A review of postmarketing cases reported to FDA and published in the literature

Photodermatology, photoimmunology & photomedicine, 2023-05, Vol.39 (3), p.285-290

2023

Volltextzugriff (PDF)

Solid Organ Transplant Rejection Associated with the Use of the Immunomodulatory Drugs (IMIDs)

Blood, 2019-11, Vol.134 (Supplement_1), p.2189-2189

2019

Volltextzugriff (PDF)

U.S. Food and Drug Administration Analysis of Newly Identified Adverse Events With Lurbinectedin: Extravasation, Rhabdomyolysis, and Tumor Lysis Syndrome

Clinical lung cancer, 2022-12, Vol.23 (8), p.e556-e562

2022

Volltextzugriff (PDF)

Postmarketing safety review of everolimus and cardiac failure or left ventricular dysfunction

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e18226-e18226

2016

Volltextzugriff (PDF)

Proteasome inhibitor‐associated thrombotic microangiopathy: A review of cases reported to the FDA adverse event reporting system and published in the literature

American journal of hematology, 2020-09, Vol.95 (9), p.E218-E222

2020

Volltextzugriff (PDF)

Varicella zoster virus reactivation reported with isatuximab use

Journal of chemotherapy (Florence), 2024-05, Vol.36 (3), p.198-201

2024

Volltextzugriff (PDF)

BCR‐ABL1 tyrosine kinase inhibitor‐associated thyroid dysfunction: A review of cases reported to the FDA Adverse Event Reporting System and published in the literature

American journal of hematology, 2020-12, Vol.95 (12), p.E332-E335

2020

Volltextzugriff (PDF)

Abiraterone acetate-associated QT prolongation and torsades de pointes: Postmarketing cases reported to FDA

Journal of oncology pharmacy practice, 2021-07, Vol.27 (5), p.1315-1316

2021

Volltextzugriff (PDF)

Association of Daratumumab Use With Ocular Events in a Case Series of US Adults

JAMA oncology, 2022-08, Vol.8 (8), p.1209

2022

Volltextzugriff (PDF)

Cisplatin-Associated Aortic Thrombosis

JACC CardioOncology, 2021-03, Vol.3 (1), p.165

2021

Volltextzugriff (PDF)

Fatal neutropenic enterocolitis associated with docetaxel use: A review of cases reported to the United States Food and Drug Administration Adverse Event Reporting System

Journal of oncology pharmacy practice, 2020-06, Vol.26 (4), p.923-928

2020

Volltextzugriff (PDF)

Cisplatin-Associated Aortic Thrombosis: A Review of Cases Reported to the FDA Adverse Event Reporting System

JACC CardioOncology, 2021-03, Vol.3 (1), p.165-165

2021

Volltextzugriff (PDF)

Ibrutinib-associated ventricular arrhythmia in the FDA Adverse Event Reporting System

Leukemia & Lymphoma, 2018, Vol.59 (12), p.3016-3017

2018

Volltextzugriff (PDF)

1 – 18 von 18

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(17)
Berichte
(1)

Sprache

Englisch
(18)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(13)
Science & Technology
(13)
Humans
(10)
Oncology
(8)
Hematology
(5)
United States Food And Drug Administration
(5)
Female
(4)
Male
(4)
Middle Aged
(4)
Pharmacology & Pharmacy
(4)
Adult
(3)
Adverse Drug Reaction Reporting Systems
(3)
Aged
(3)
Databases, Factual
(3)
Multiple Myeloma - Drug Therapy
(3)
United States
(3)
United States - Epidemiology
(3)
Cardiovascular System & Cardiology
(2)
Fda Approval
(2)
Pharmacovigilance
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ibrutinib-associated ventricular arrhythmia in the FDA Adverse Event Reporting System

Hemolytic anemia following alectinib reported to the U.S. Food and Drug Administration Adverse Event Reporting System

Arterial aneurysm and dissection with systemic vascular endothelial growth factor inhibitors: A review of cases reported to the FDA Adverse Event Reporting System and published in the literature

Ibrutinib‐associated Pneumocystis jirovecii pneumonia

Wound healing complications with lenvatinib identified in a pharmacovigilance database

Photosensitivity associated with anaplastic lymphoma kinase inhibitors: A review of postmarketing cases reported to FDA and published in the literature

Solid Organ Transplant Rejection Associated with the Use of the Immunomodulatory Drugs (IMIDs)

U.S. Food and Drug Administration Analysis of Newly Identified Adverse Events With Lurbinectedin: Extravasation, Rhabdomyolysis, and Tumor Lysis Syndrome

Postmarketing safety review of everolimus and cardiac failure or left ventricular dysfunction

Proteasome inhibitor‐associated thrombotic microangiopathy: A review of cases reported to the FDA adverse event reporting system and published in the literature

Varicella zoster virus reactivation reported with isatuximab use

BCR‐ABL1 tyrosine kinase inhibitor‐associated thyroid dysfunction: A review of cases reported to the FDA Adverse Event Reporting System and published in the literature

Abiraterone acetate-associated QT prolongation and torsades de pointes: Postmarketing cases reported to FDA

Association of Daratumumab Use With Ocular Events in a Case Series of US Adults

Cisplatin-Associated Aortic Thrombosis

Fatal neutropenic enterocolitis associated with docetaxel use: A review of cases reported to the United States Food and Drug Administration Adverse Event Reporting System

Cisplatin-Associated Aortic Thrombosis: A Review of Cases Reported to the FDA Adverse Event Reporting System

Ibrutinib-associated ventricular arrhythmia in the FDA Adverse Event Reporting System

Suchergebnisse filtern